---
category: news
title: "No Hints of Cognitive Defects With ARNIs in HFpEF: PERSPECTIVE"
excerpt: "BARCELONA, Spainâ€”(UPDATED) There are no signs that sacubitril/valsartan (Entresto; Novartis) has any negative impact on cognitive function in people who have heart failure with preserved ejection fraction (HFpEF), at least over a 3-year period ..."
publishedDateTime: 2022-08-27T07:36:00Z
originalUrl: "https://www.tctmd.com/news/no-hints-cognitive-defects-arnis-hfpef-perspective"
webUrl: "https://www.tctmd.com/news/no-hints-cognitive-defects-arnis-hfpef-perspective"
type: article

provider:
  name: TCTMD
  domain: tctmd.com

topics:
  - Microsoft AI
  - AI

images:
  - url: "https://d18mqtxkrsjgmh.cloudfront.net/public/2022-08/No%20Hints%20of%20Cognitive%20Defects%20With%20ARNIs%20in%20HFpEF.jpg"
    width: 1207
    height: 682
    isCached: true

secured: "PdCjEhSXMDEDpKWmgWz+Wg1uHlBnIpYXF0yyGaMqtL7Soc/USKkSOteImZFLi7SjHv1vl+o+sdJO+h67UdKQ70lrLWyS5U2MAMBjEoc2F4nVRsncNvL1RkPUuuJ9MBRHDg2u2iUe5aB7VB7vuGDWTGUlHjyQcYu9eYvF69SsZBA6i3zJfYY9dHiA/DYK7o2m7DmWiy6Wi+zjyGGrqm3L7wq74rR/QlIHaGe0mzSjksHmSETAVxEqCSH4Pn6KPBdjgyZqqiIgNNKk0t2mX+zajnPJ5miw937O04IahySxruKJ1D7YZk1SUtr4s7mvf/0fAK8ZFt2fgiGH0dSX6YKhpG/cUvmEAT0ZWbptz48kJz4=;N+dWDuHtwHMSC0xM6rP45w=="
---

